STATE STREET CORP - INOZYME PHARMA INC ownership

INOZYME PHARMA INC's ticker is INZY and the CUSIP is 45790W108. A total of 78 filers reported holding INOZYME PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of INOZYME PHARMA INC
ValueSharesWeighting
Q3 2023$2,639,057
-15.5%
628,347
+12.0%
0.00%
Q2 2023$3,123,890
+456.0%
560,842
+472.0%
0.00%
Q1 2023$561,855
+250.4%
98,055
-35.8%
0.00%
Q4 2022$160,346
-21.8%
152,710
+100.0%
0.00%
Q3 2022$205,000
-12.4%
76,355
+55.7%
0.00%
Q2 2022$234,000
-69.7%
49,055
-74.0%
0.00%
Q1 2022$773,000
-39.4%
189,005
+1.0%
0.00%
Q4 2021$1,276,000
-41.5%
187,102
-0.6%
0.00%
Q3 2021$2,182,000
-24.6%
188,267
+10.8%
0.00%
Q2 2021$2,895,000
+10.6%
169,889
+28.5%
0.00%
Q1 2021$2,618,000
+7.9%
132,219
+12.5%
0.00%
Q4 2020$2,427,000
+30.8%
117,579
+66.6%
0.00%
Q3 2020$1,856,00070,5850.00%
Other shareholders
INOZYME PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 4,494,851$18,878,3747.53%
CHI Advisors LLC 1,270,027$5,334,1122.11%
Samsara BioCapital, LLC 1,562,500$6,562,5002.01%
Affinity Asset Advisors, LLC 1,379,852$5,795,3781.63%
Sofinnova Investments, Inc. 4,280,308$17,977,2941.13%
SPHERA FUNDS MANAGEMENT LTD. 1,234,907$5,186,6090.94%
Octagon Capital Advisors LP 1,300,000$5,460,0000.84%
NEA Management Company, LLC 2,437,689$10,238,2940.79%
Knott David M Jr 454,008$1,9070.73%
Rock Springs Capital Management LP 3,681,174$15,460,9310.41%
View complete list of INOZYME PHARMA INC shareholders